Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy.
Yen-Chun ChenPing-Hung KoChi-Che LeeChih-Wei TsengKuo-Chih TsengPublished in: BMC gastroenterology (2021)
BL TPO level might be a useful marker for predicting significant platelet count improvement in thrombocytopenic patients after successful DAA therapy.